Drugs Made In America Acquisition II Corp Right
DMIIR
61 hedge funds and large institutions have $3.29M invested in Drugs Made In America Acquisition II Corp Right in 2026 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 0 closing their positions.
7% more funds holding
Funds holding: 57 → 61 (+4)
1% more capital invested
Capital invested by funds: $3.25M → $3.29M (+$35.1K)
25% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TAL
TIG Advisors LLC
New York
|
+$42.8K |
| 2 |
SAMU
SONA Asset Management (US)
New York
|
+$21.4K |
| 3 |
KC
Kepos Capital
New York
|
+$16.1K |
| 4 |
CS
Clear Street
New York
|
+$13.2K |
| 5 |
SG
StoneX Group
New York
|
+$8.55K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$33.5K |
| 2 |
MC
Meteora Capital
Boca Raton,
Florida
|
-$2.3K |
| 3 |
BFM
Boothbay Fund Management
New York
|
-$1.17K |
| 4 |
HCM
Heights Capital Management
San Francisco,
California
|
-$964 |
| 5 |
KC
Kryger Capital
London,
United Kingdom
|
-$714 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CCC
51
Cable Car Capital
San Francisco,
California
| $8K | – | – | – |
|
52
PEAK6
Chicago,
Illinois
| $8K | – | – | – |
|
|
SG
53
StoneX Group
New York
| $7.96K | +$8.55K | +100,000 | New |
|
|
CC
54
Centiva Capital
New York
| $7.27K | – | – | – |
|
|
SSA
55
Schonfeld Strategic Advisors
New York
| $7.08K | – | – | – |
|
|
AAP
56
Arax Advisory Partners
Denver,
Colorado
| $5.28K | +$5.64K | +65,990 | New |
|
|
PCM
57
PenderFund Capital Management
Vancouver,
British Columbia, Canada
| $3.61K | – | – | – |
|
|
AA
58
ABC Arbitrage
Paris,
France
| $3.2K | – | – | – |
|
|
VF
59
Virtu Financial
New York
| $3K | -$46 | -533 | -1% |
|
|
RCM
60
Robinson Capital Management
Grosse Pointe Farms,
Michigan
| $1.82K | – | – | – |
|
61
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | – | – | – |
|
62
UBS Group
Zurich,
Switzerland
| $20 | – | – | – |
|
DMIIR Hedge Fund Activity: Q2 2026 in Review
61 of the 8,279 institutional investors tracked by Wall St. Rank reported a position in Drugs Made In America Acquisition II Corp Right (DMIIR) for Q2 2026, worth a combined $3.29M — up 1.1% from $3.25M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new DMIIR positions and 0 closed out — a net gain of 4 holders — while 6 added to existing stakes and 8 trimmed.
The largest buyer was TIG Advisors LLC, opening a new position worth an estimated $42.8K. The largest seller was Hudson Bay Capital Management, cutting an estimated $33.5K.
- 61 institutional investors held Drugs Made In America Acquisition II Corp Right (DMIIR) as of Q2 2026, up from 57 in Q1 2026.
- Funds reported $3.29M of Drugs Made In America Acquisition II Corp Right stock for Q2 2026, up 1.1% quarter-over-quarter.
- 4 funds opened new Drugs Made In America Acquisition II Corp Right positions in Q2 2026 and 0 closed out, a net change of +4 holders.
- The largest Drugs Made In America Acquisition II Corp Right buyer in Q2 2026 was TIG Advisors LLC, an estimated $42.8K added.
- The largest Drugs Made In America Acquisition II Corp Right seller in Q2 2026 was Hudson Bay Capital Management, an estimated $33.5K sold.
Based on aggregated 13F filings for Q2 2026.